| 1 | 15943473 | Design, synthesis, and evaluation of orally active 4-(2,4-difluoro-5-(methoxycarbamoyl)phenylamino)pyrrolo[2,1-f][1,2,4]triazines as dual vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1 inhibitors. | J Med Chem | 2005 Jun 16 |
1 |
| 2 | 16111887 | New dual inhibitors of EGFR and HER2 protein tyrosine kinases. | Bioorg Med Chem Lett | 2005 Nov 1 |
2 |
| 3 | 18072718 | Design, synthesis, and anti-inflammatory properties of orally active 4-(phenylamino)-pyrrolo[2,1-f][1,2,4]triazine p38alpha mitogen-activated protein kinase inhibitors. | J Med Chem | 2008 Jan 10 |
1 |
| 4 | 18221875 | Synthesis, SAR, and Evaluation of 4-[2,4-Difluoro-5-(cyclopropylcarbamoyl)phenylamino]pyrrolo[2,1-f][1,2,4]triazine-based VEGFR-2 kinase inhibitors. | Bioorg Med Chem Lett | 2008 Feb 15 |
2 |
| 5 | 18364256 | Synthesis and SAR of new pyrrolo[2,1-f][1,2,4]triazines as potent p38 alpha MAP kinase inhibitors. | Bioorg Med Chem Lett | 2008 Apr 15 |
2 |
| 6 | 21705217 | Discovery of pyrrolo[2,1-f][1,2,4]triazine C6-ketones as potent, orally active p38α MAP kinase inhibitors. | Bioorg Med Chem Lett | 2011 Aug 1 |
1 |
| 7 | 21859094 | 2,7-disubstituted-pyrrolo[2,1-f][1,2,4]triazines: new variant of an old template and application to the discovery of anaplastic lymphoma kinase (ALK) inhibitors with in vivo antitumor activity. | J Med Chem | 2011 Sep 22 |
2 |
| 8 | 25139565 | Fragment-based identification and optimization of a class of potent pyrrolo[2,1-f][1,2,4]triazine MAP4K4 inhibitors. | Bioorg Med Chem Lett | 2014 Sep 15 |
1 |
| 9 | 30248654 | Exploration of novel pyrrolo[2,1-f][1,2,4]triazine derivatives with improved anticancer efficacy as dual inhibitors of c-Met/VEGFR-2. | Eur J Med Chem | 2018 Oct 5 |
2 |
| 10 | 31670202 | Corrigendum to 'Exploration of novel pyrrolo[2,1-f][1,2,4]triazine derivatives with improved anticancer efficacy as dual inhibitors of c-Met/VEGFR-2' [European journal of medicinal chemistry 158 (2018) 814-831]. | Eur J Med Chem | 2020 Jan 1 |
2 |